Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Navigator: ABT-450/r + ABT-267 +/- RBV in HCV
NCT01458535Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2011
- Primary completion
- May 2013
- Modality
- Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 2 trial of paritaprevir, ombitasvir in hepatitis C (HCV), sponsored by AbbVie Inc.. Started Sep 2011; status: completed.
02
Drugs
paritaprevirombitasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01458535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458535.